NOVAGO THERAPEUTICS
NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics targeting cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. A strategic partnership with Neurimmune provides access to a unique class of human-derived antibodies with exceptional therapeutic properties generated through their Reverse Translational Medicineâ„¢ (RTMâ„¢) technology platform.
NOVAGO THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2015-03-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.novagotherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Alentis Therapeutics
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
CT Atlantic
CT Atlantic AG is a swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Kinled Holding
Kinled Holding investment in Series A - NovaGo Therapeutics
Neurimmune Holding
Neurimmune Holding investment in Series A - NovaGo Therapeutics
Pureos Bioventures
Pureos Bioventures investment in Series A - NovaGo Therapeutics
Official Site Inspections
http://www.novagotherapeutics.com
- Host name: bezier.ch-meta.net
- IP address: 80.74.154.66
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "NovaGo Therapeutics"
NovaGo – Therapeutics
Founded in 2015 in Zurich-Schlieren, Switzerland, NovaGo Therapeutics is a biotech company focused on human antibody therapeutics targeting nerve growth and regeneration.See details»
Company – NovaGo - NovaGo – Therapeutics
Founded in 2015 in Schlieren, Switzerland, NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics targeting nerve growth and regeneration for …See details»
Strategy – NovaGo - NovaGo – Therapeutics
We are interested in partnerships with organizations that provide complimentary expertise and resources to maximize the commercial value of our drug candidates. For further information on …See details»
NovaGo Therapeutics - Crunchbase Company Profile
Contact Email [email protected] NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody …See details»
NovaGo Therapeutics AG – Swiss Biotech
NovaGo Therapeutics is a Swiss biotech company focused on human antibody therapeutics targeting nerve growth and regeneration to enhance functional recovery following spinal cord injury. Phase 1 clinical trials for the treatment of …See details»
NovaGo Therapeutics - LinkedIn
NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics for spinal cord injury | NovaGo’s fully human monoclonal antibodies have the potential to...See details»
NovaGo Therapeutics at the Swiss Biotech Day
NovaGo Therapeutics is a Swiss biotech company focused on human antibody therapeutics targeting nerve growth and regeneration to enhance functional recovery following spinal cord …See details»
NovaGo Therapeutics AG - VentureRadar
Website: http://www.novagotherapeutics.com/ Develops human antibody therapeutics targeting blood vessel and nerve growth/regeneration by blocking Nogo-A, aiming for ophthalmology …See details»
NovaGo Therapeutics AG - startup.ch
NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics targeting cerebral stroke and spinal cord injury to stimulate nerve repair …See details»
People – NovaGo - Therapeutics
Since 2002, on the Board of the Swiss Biotech Association and President since 2013. PhD Molecular Biologist. Prof. Roger M. Nitsch is a neuroscientist with a background in medicine, recognized as a key opinion leader in …See details»
NovaGo Therapeutics AG - Company Profile and News
NovaGo Therapeutics AG operates as a biotechnology company. The Company offers treatment for stroke and spinal cord injury. NovaGo Therapeutics serves patients in Switzerland.See details»
Novel regenerative treatments for CNS disorders and cerebral stroke
Biotech start-up company NovaGo is developing human antibodies that stimulate nerve repair and regeneration following a stroke. The company’s lead candidate anti-Nogo-A antibody (NG004) …See details»
Novago Therapeutics Ag - Schlieren 8952 (Bezirk Dietikon
Die Gesellschaft bezweckt die Entwicklung von biopharmazeutischen Produkten, insbesondere im Bereich von Erkrankungen des Nervensystems und des kardiovaskulären Systems und vergibt …See details»
NovaGo Company Profile 2024: Valuation, Funding & Investors
Developer of human antibody therapeutics designed to target blood vessel growth, nerve growth, and regeneration.See details»
Science – NovaGo - NovaGo – Therapeutics
NovaGo develops human therapeutic antibodies to enhance nerve growth and regeneration by blocking the growth inhibitory membrane protein Nogo-A. This blockade of Nogo-A function …See details»
NovaGo Therapeutics raises CHF 10 million to develop
Apr 3, 2019 · NovaGo Therapeutics AG, a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke, has closed a Series A financing …See details»
Novel regenerative treatments for CNS disorders and cerebral stroke
NovaGo Therapeutics, a biotech start-up company that develops human antibodies that stimulate nerve repair and regeneration, is set to address this large unmet medical need.See details»
NovaGo Therapeutics: Developing Human Antibody Therapeutics …
NovaGo Therapeutics is one such biotech start-up dedicated to the development of human antibody therapeutics targeting cerebral stroke to stimulate nerve repair and regeneration.See details»
Company News - NovaGo
Novago Therapeutics AG announces that Roger Wetli was appointed as Chief Financial Officer of the company effective January 01, 2024. Roger Wetli will lead the finance and accounting …See details»
NovaGo Therapeutics - Company Profile & Staff Directory
NovaGo’s fully human monoclonal antibodies have the potential to become a safe and effective treatment in central nervous system indications. NovaGo’s proprietary antibodies block the …See details»